Document is current
Any future updates will be listed below
-
Authors
Elbuluk, Nada https://orcid.org/0000-0002-5956-4404
Saizan, Autumn L.
Hurtado, Arielle Carolina Mora
Hamilton, Ted
Kang, Sewon
-
Funding
Funding for this research was provided by:
University of Southern California
- License Information
-
More Information
Article History
Received: 24 November 2024
Revised: 7 February 2025
Accepted: 12 February 2025
First Online: 18 March 2025
Declarations
:
: The study was reviewed and approved by the University of Michigan Institutional Review Board.
: All patients in this manuscript have given written informed consent for participation in the study and the use of their de-identified, anonymized, aggregated data and their case details (including photographs) for publication.
: Dr. Elbuluk has served as a consultant, advisory board member, and/or speaker for Avita, Scientis, Incyte, VisualDx, La Roche Posay, Beiersdorf, Unilever, Eli Lilly, Galderma, Pfizer, L’Oreal, McGraw Hill, Dior, Medscape, Abbvie, Takeda, Sanofi. She has received royalties from McGraw-Hill. She has stock options in VisualDx.Dr. Kang has served as a consultant or advisory board member for Amorepacific, CeraVe, Eli Lilly, Galderma, Krystal Biotech, and Unilever.The remaining authors have no conflicts of interest to disclose.
